|
Real-time Estimate
Cboe BZX
20:58:24 03/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 181.82 USD | +1.36% |
|
+1.96% | +60.54% |
| 08-25 | Davita Inc. Announces New Value-Based Partnership with Humana Inc. to Expand Care for Patients with Chronic Kidney Disease | CI |
| 08-25 | DaVita Reaches Kidney Care Agreement With Humana | MT |
| Market Cap | 11.44B 9.84B 9.24B 8.45B 15.77B 1,081B 15.9B 109B 42.55B 553B 42.96B 42.02B 1,780B | P/E 2026 * |
12.3x | P/E 2027 * | 10.5x |
|---|---|---|---|---|---|
| Enterprise Value | 22.26B 19.16B 17.98B 16.45B 30.7B 2,105B 30.94B 213B 82.81B 1,076B 83.6B 81.78B 3,464B | EV / Sales 2026 * |
1.57x | EV / Sales 2027 * | 1.52x |
| Free-Float |
49.06% | Yield 2026 * |
0.93% | Yield 2027 * | 0.93% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| DVA | Delayed | |
CBOE
| DVA | Real-time | |
|
London S.E.
| 0I7E | Delayed | |
|
Boerse Muenchen
| TRL | Real-time | |
|
Tradegate
| TRL | Real-time | |
|
Mexican S.E.
| DVA * | End-of-day quote | |
|
Xetra
| TRL | Delayed | |
|
Deutsche Boerse AG
| TRL | Delayed | |
|
Börse Stuttgart
| TRL | Delayed | |
|
Berne S.E.
| TRL | End-of-day quote | |
|
Borsa Italiana
| 1DVA | End-of-day quote |
Last Transcript : DaVita Inc.
| 1 day | +1.34% | ||
| 1 week | +1.96% | ||
| Current month | +3.62% | ||
| 1 month | -21.95% | ||
| 3 months | -6.48% | ||
| 6 months | +19.78% | ||
| Current year | +60.54% |
| 1 week | 175.47 |  | 183.34 |
| 1 month | 171.4 | | 234.26 |
| Current year | 101 | | 247.49 |
| 1 year | 101 | | 247.49 |
| 3 years | 71.51 | | 247.49 |
| 5 years | 65.28 | | 247.49 |
| 10 years | 43.4 | | 247.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
Javier Rodriguez
CEO | Chief Executive Officer | 65 | 31/05/2019 |
Joel Ackerman
DFI | Director of Finance/CFO | 61 | 26/02/2017 |
Madhu Narasimhan
CTO | Chief Tech/Sci/R&D Officer | - | 02/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Pamela Arway
CHM | Chairman | 72 | 31/05/2020 |
Barbara Desoer
BRD | Director/Board Member | 73 | 07/10/2015 |
Javier Rodriguez
BRD | Director/Board Member | 65 | 31/05/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 15/08/26 | Free | Director | 278 | 0.0004% | ||
| 15/08/26 | Free | Chairman | 278 | 0.0004% | ||
| 15/08/26 | Free | Director | 278 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.36% | +1.96% | +34.14% | +88.71% | 11.44B | |
| -0.09% | +4.54% | +32.49% | +48.06% | 124B | |
| +1.92% | -1.96% | +0.86% | +49.90% | 87.05B | |
| -3.36% | -1.06% | -1.39% | +55.76% | 29.19B | |
| -0.52% | -2.23% | +33.23% | +87.96% | 26.58B | |
| -0.26% | -4.48% | -4.92% | -5.03% | 21.51B | |
| +1.98% | -1.41% | +41.23% | +244.43% | 20.82B | |
| +1.00% | +6.17% | -4.07% | +28.83% | 15.85B | |
| -1.93% | -3.81% | -7.88% | -13.41% | 12.09B | |
| +0.02% | -1.37% | -14.50% | +73.07% | 10.24B | |
| Average | +0.01% | -1.45% | +10.92% | +65.83% | 35.91B | |
| Weighted average by Cap. | +0.25% | -1.01% | +16.13% | +59.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 14.16B 12.18B 11.43B 10.46B 19.52B 1,338B 19.68B 135B 52.66B 684B 53.17B 52.01B 2,203B | 14.6B 12.57B 11.79B 10.79B 20.14B 1,381B 20.3B 139B 54.32B 706B 54.84B 53.65B 2,272B |
| Net income | 933M 803M 753M 689M 1.29B 88.19B 1.3B 8.91B 3.47B 45.07B 3.5B 3.43B 145B | 1.02B 874M 820M 750M 1.4B 96B 1.41B 9.7B 3.78B 49.06B 3.81B 3.73B 158B |
| Net Debt | 10.82B 9.31B 8.74B 8B 14.92B 1,023B 15.04B 103B 40.26B 523B 40.65B 39.76B 1,684B | 10.8B 9.29B 8.72B 7.98B 14.89B 1,021B 15.01B 103B 40.18B 522B 40.56B 39.68B 1,681B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/09/26 | US$182.39 | +1.67% | 374,197 |
| 02/09/26 | US$179.39 | +1.85% | 513,511 |
| 01/09/26 | US$176.14 | +0.07% | 672,631 |
| 31/08/26 | US$176.01 | -2.58% | 573,911 |
| 28/08/26 | US$180.68 | +1.01% | 461,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DVA Stock
Select your edition
All financial news and data tailored to specific country editions
